696 related articles for article (PubMed ID: 9528941)
1. Multiple splicing events involved in regulation of human aromatase expression by a novel promoter, I.6.
Shozu M; Zhao Y; Bulun SE; Simpson ER
Endocrinology; 1998 Apr; 139(4):1610-7. PubMed ID: 9528941
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the sequences of the human CYP19 (aromatase) gene that mediate regulation by glucocorticoids in adipose stromal cells and fetal hepatocytes.
Zhao Y; Mendelson CR; Simpson ER
Mol Endocrinol; 1995 Mar; 9(3):340-9. PubMed ID: 7776980
[TBL] [Abstract][Full Text] [Related]
3. Characterization of a region upstream of exon I.1 of the human CYP19 (aromatase) gene that mediates regulation by retinoids in human choriocarcinoma cells.
Sun T; Zhao Y; Mangelsdorf DJ; Simpson ER
Endocrinology; 1998 Apr; 139(4):1684-91. PubMed ID: 9528950
[TBL] [Abstract][Full Text] [Related]
4. Tumor necrosis factor-alpha stimulates aromatase gene expression in human adipose stromal cells through use of an activating protein-1 binding site upstream of promoter 1.4.
Zhao Y; Nichols JE; Valdez R; Mendelson CR; Simpson ER
Mol Endocrinol; 1996 Nov; 10(11):1350-7. PubMed ID: 8923461
[TBL] [Abstract][Full Text] [Related]
5. Estrogen biosynthesis in THP1 cells is regulated by promoter switching of the aromatase (CYP19) gene.
Shozu M; Zhao Y; Simpson ER
Endocrinology; 1997 Dec; 138(12):5125-35. PubMed ID: 9389492
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the regulatory regions of the human aromatase (P450arom) gene involved in placenta-specific expression.
Kamat A; Alcorn JL; Kunczt C; Mendelson CR
Mol Endocrinol; 1998 Nov; 12(11):1764-77. PubMed ID: 9817601
[TBL] [Abstract][Full Text] [Related]
7. Quantitative detection of alternatively spliced transcripts of the aromatase cytochrome P450 (CYP19) gene in aromatase-expressing human cells by competitive RT-PCR.
Agarwal VR; Bulun SE; Simpson ER
Mol Cell Probes; 1995 Dec; 9(6):453-64. PubMed ID: 8808317
[TBL] [Abstract][Full Text] [Related]
8. Cloning and characterization of a novel endothelial promoter of the human CYP19 (aromatase P450) gene that is up-regulated in breast cancer tissue.
Sebastian S; Takayama K; Shozu M; Bulun SE
Mol Endocrinol; 2002 Oct; 16(10):2243-54. PubMed ID: 12351690
[TBL] [Abstract][Full Text] [Related]
9. Use of alternative promoters to express the aromatase cytochrome P450 (CYP19) gene in breast adipose tissues of cancer-free and breast cancer patients.
Agarwal VR; Bulun SE; Leitch M; Rohrich R; Simpson ER
J Clin Endocrinol Metab; 1996 Nov; 81(11):3843-9. PubMed ID: 8923826
[TBL] [Abstract][Full Text] [Related]
10. Novel promoter I.8 and promoter usage in the CYP19 (aromatase) gene.
Demura M; Reierstad S; Innes JE; Bulun SE
Reprod Sci; 2008 Dec; 15(10):1044-53. PubMed ID: 18955734
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of aromatase P450 in leiomyoma tissue is driven primarily through promoter I.4 of the aromatase P450 gene (CYP19).
Shozu M; Sumitani H; Segawa T; Yang HJ; Murakami K; Kasai T; Inoue M
J Clin Endocrinol Metab; 2002 Jun; 87(6):2540-8. PubMed ID: 12050211
[TBL] [Abstract][Full Text] [Related]
12. Tissue-specific expression of the bovine aromatase-encoding gene uses multiple transcriptional start sites and alternative first exons.
Fürbass R; Kalbe C; Vanselow J
Endocrinology; 1997 Jul; 138(7):2813-9. PubMed ID: 9202222
[TBL] [Abstract][Full Text] [Related]
13. Aromatase expression of human osteoblast-like cells.
Shozu M; Simpson ER
Mol Cell Endocrinol; 1998 Apr; 139(1-2):117-29. PubMed ID: 9705080
[TBL] [Abstract][Full Text] [Related]
14. Use of tissue-specific promoters in the regulation of aromatase cytochrome P450 gene expression in human testicular and ovarian sex cord tumors, as well as in normal fetal and adult gonads.
Bulun SE; Rosenthal IM; Brodie AM; Inkster SE; Zeller WP; DiGeorge AM; Frasier SD; Kilgore MW; Simpson ER
J Clin Endocrinol Metab; 1994 Feb; 78(2):1616-21. PubMed ID: 8106605
[TBL] [Abstract][Full Text] [Related]
15. Malignant breast epithelial cells stimulate aromatase expression via promoter II in human adipose fibroblasts: an epithelial-stromal interaction in breast tumors mediated by CCAAT/enhancer binding protein beta.
Zhou J; Gurates B; Yang S; Sebastian S; Bulun SE
Cancer Res; 2001 Mar; 61(5):2328-34. PubMed ID: 11280806
[TBL] [Abstract][Full Text] [Related]
16. Tissue-specific promoters regulate aromatase cytochrome P450 gene expression in human ovary and fetal tissues.
Means GD; Kilgore MW; Mahendroo MS; Mendelson CR; Simpson ER
Mol Endocrinol; 1991 Dec; 5(12):2005-13. PubMed ID: 1724289
[TBL] [Abstract][Full Text] [Related]
17. Aberrant expression of aromatase in breast cancer tissues.
Harada N
J Steroid Biochem Mol Biol; 1997 Apr; 61(3-6):175-84. PubMed ID: 9365188
[TBL] [Abstract][Full Text] [Related]
18. The cytochrome P450 aromatase lacking exon 5 is associated with a phenotype of nonclassic aromatase deficiency and is also present in normal human steroidogenic tissues.
Pepe CM; Saraco NI; Baquedano MS; Guercio G; Vaiani E; Marino R; Pandey AV; Flück CE; Rivarola MA; Belgorosky A
Clin Endocrinol (Oxf); 2007 Nov; 67(5):698-705. PubMed ID: 17608756
[TBL] [Abstract][Full Text] [Related]
19. Transcriptional regulation of the mouse PNRC2 promoter by the nuclear factor Y (NFY) and E2F1.
Zhou D; Masri S; Ye JJ; Chen S
Gene; 2005 Nov; 361():89-100. PubMed ID: 16181749
[TBL] [Abstract][Full Text] [Related]
20. Gene regulation studies of aromatase expression in breast cancer and adipose stromal cells.
Zhou D; Zhou C; Chen S
J Steroid Biochem Mol Biol; 1997 Apr; 61(3-6):273-80. PubMed ID: 9365201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
